IL150527A0 - Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives - Google Patents
Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivativesInfo
- Publication number
- IL150527A0 IL150527A0 IL15052701A IL15052701A IL150527A0 IL 150527 A0 IL150527 A0 IL 150527A0 IL 15052701 A IL15052701 A IL 15052701A IL 15052701 A IL15052701 A IL 15052701A IL 150527 A0 IL150527 A0 IL 150527A0
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- vitamin
- osteoporosis
- treatment
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17942600P | 2000-01-31 | 2000-01-31 | |
PCT/DK2001/000069 WO2001056981A1 (fr) | 2000-01-31 | 2001-01-31 | Utilisation de derives de vitamine d dans le traitement de l'osteoporose et de maladies osseuses associees, et nouveaux derives de vitamine d3 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150527A0 true IL150527A0 (en) | 2003-02-12 |
Family
ID=22656548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15052701A IL150527A0 (en) | 2000-01-31 | 2001-01-31 | Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
Country Status (14)
Country | Link |
---|---|
US (1) | US7071178B2 (fr) |
EP (1) | EP1255732A1 (fr) |
JP (1) | JP2003521531A (fr) |
KR (1) | KR20020080396A (fr) |
CN (1) | CN1396910A (fr) |
AU (1) | AU776755B2 (fr) |
BR (1) | BR0107969A (fr) |
CA (1) | CA2399083A1 (fr) |
HU (1) | HUP0204258A3 (fr) |
IL (1) | IL150527A0 (fr) |
MX (1) | MXPA02007339A (fr) |
PL (1) | PL356366A1 (fr) |
RU (1) | RU2253455C2 (fr) |
WO (1) | WO2001056981A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505884A (ja) * | 2003-09-19 | 2007-03-15 | ファイザー・プロダクツ・インク | 骨減少症又は男性の骨粗しょう症の治療のための2−アルキリデン−19−ノル−ビタミンd誘導体 |
AU2008242711A1 (en) * | 2007-04-18 | 2008-10-30 | Johns Hopkins University | Low calcemic, highly antiproliferative, analogs of calcitriol |
US8377913B2 (en) * | 2007-11-20 | 2013-02-19 | Abbvie Inc. | Vitamin D receptor activators and methods of making |
EP2393494A1 (fr) * | 2009-01-27 | 2011-12-14 | Berg Biosystems, LLC | Vitamines d3 et analogues de celles-ci pour soulagement des effets secondaires associés à une chimiothérapie |
CN106008301B (zh) * | 2016-05-24 | 2017-12-26 | 中国医药集团总公司四川抗菌素工业研究所 | 26‑甲基‑25‑羟基维生素d3化合物及其制备方法和应用 |
KR101983654B1 (ko) * | 2018-07-24 | 2019-05-29 | 한국과학기술원 | Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3163836A (en) * | 1952-04-14 | 1964-12-29 | Sumitomo Electric Industries | Coaxial conductor having parallel connected stranded layers of different pitch for equalizing inductance and current distribution |
US3588317A (en) * | 1968-11-08 | 1971-06-28 | Simplex Wire & Cable Co | Shielded cable |
GB2114570B (en) * | 1981-11-02 | 1985-08-07 | Res Inst Medicine Chem | Chemical compounds |
DE3524082A1 (de) * | 1985-07-05 | 1987-01-08 | Bbc Brown Boveri & Cie | Supraleitende faser und verfahren zu deren herstellung |
GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
KR960013798B1 (ko) * | 1992-04-24 | 1996-10-10 | 재단법인 한국전자통신연구소 | 평면 도파로형 공간 스위치 |
DE19520589A1 (de) * | 1995-06-06 | 1996-12-12 | Siemens Ag | Wechselstromkabel mit verseilten elektrischen Leitern |
US5929385A (en) * | 1996-05-10 | 1999-07-27 | The Furukawa Electric Co., Ltd | AC oxide superconductor wire and cable |
-
2001
- 2001-01-31 WO PCT/DK2001/000069 patent/WO2001056981A1/fr not_active Application Discontinuation
- 2001-01-31 KR KR1020027009792A patent/KR20020080396A/ko not_active Application Discontinuation
- 2001-01-31 CA CA002399083A patent/CA2399083A1/fr not_active Abandoned
- 2001-01-31 EP EP01948978A patent/EP1255732A1/fr not_active Withdrawn
- 2001-01-31 AU AU28329/01A patent/AU776755B2/en not_active Ceased
- 2001-01-31 CN CN01804344A patent/CN1396910A/zh active Pending
- 2001-01-31 HU HU0204258A patent/HUP0204258A3/hu unknown
- 2001-01-31 IL IL15052701A patent/IL150527A0/xx unknown
- 2001-01-31 MX MXPA02007339A patent/MXPA02007339A/es unknown
- 2001-01-31 RU RU2002123409/15A patent/RU2253455C2/ru not_active IP Right Cessation
- 2001-01-31 BR BR0107969-7A patent/BR0107969A/pt not_active IP Right Cessation
- 2001-01-31 US US09/787,548 patent/US7071178B2/en not_active Expired - Fee Related
- 2001-01-31 JP JP2001556831A patent/JP2003521531A/ja active Pending
- 2001-01-31 PL PL01356366A patent/PL356366A1/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2003521531A (ja) | 2003-07-15 |
AU776755B2 (en) | 2004-09-23 |
BR0107969A (pt) | 2002-10-29 |
AU2832901A (en) | 2001-08-14 |
MXPA02007339A (es) | 2004-08-11 |
WO2001056981A1 (fr) | 2001-08-09 |
US20040069523A1 (en) | 2004-04-15 |
RU2253455C2 (ru) | 2005-06-10 |
PL356366A1 (en) | 2004-06-28 |
US7071178B2 (en) | 2006-07-04 |
CA2399083A1 (fr) | 2001-08-09 |
RU2002123409A (ru) | 2004-03-10 |
HUP0204258A3 (en) | 2005-03-29 |
EP1255732A1 (fr) | 2002-11-13 |
KR20020080396A (ko) | 2002-10-23 |
CN1396910A (zh) | 2003-02-12 |
HUP0204258A2 (hu) | 2003-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401023A3 (en) | Use of flibanserin in the treatment of sexual disorders | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
AU2002361811A8 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
MXPA03008634A (es) | Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
IL150527A0 (en) | Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives | |
GB0316026D0 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
AU2002360531A8 (en) | Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201 | |
EP1328264A4 (fr) | Utilisation de phosphate d'estramustine dans le traitement de metastase osseuse | |
AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
IL162053A0 (en) | Method for the treatment of bone disorders | |
EP1539100A4 (fr) | Compositions et methodes pour le traitement de troubles cutanes | |
AU2001228330A1 (en) | Vitamin d-derivatives and their use in treating osteoporosis and related bone disorders | |
EP1589985A4 (fr) | Procede et compositions pour traiter la douleur et les troubles douloureux en utilisant 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 | |
EP1450666A4 (fr) | Procedes et compositions pour traiter des maladies cardio-vasculaires en utilisant 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 ou 93804 | |
AU2002358267A1 (en) | Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 | |
AU2003217432A8 (en) | Angiopoietin-1 in the treatment of disease | |
EP1517912A4 (fr) | Methodes et compositions de traitement de la douleur et des affections douloureuses au moyen des genes 577, 20739 ou 57145 | |
SI1425008T1 (sl) | Uporaba substituiranih aminometilkromanov za zdravljenje stranskih ucinkov nevroleptikov | |
AU2003247094A8 (en) | Enhancing the effect of radioimmunotherapy in the treatment of tumors |